| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Depression, Postpartum | 18 | 2024 | 131 | 7.620 |
Why?
|
| Pregnancy Complications | 34 | 2025 | 367 | 7.450 |
Why?
|
| Pregnancy | 102 | 2025 | 2226 | 4.950 |
Why?
|
| Depression | 23 | 2024 | 831 | 3.920 |
Why?
|
| Postpartum Period | 17 | 2024 | 189 | 3.530 |
Why?
|
| Depressive Disorder | 10 | 2024 | 279 | 3.320 |
Why?
|
| Perinatal Care | 12 | 2025 | 59 | 3.150 |
Why?
|
| Prenatal Care | 15 | 2024 | 171 | 2.990 |
Why?
|
| Obstetrics | 10 | 2025 | 82 | 2.930 |
Why?
|
| Developmental Disabilities | 7 | 2022 | 108 | 2.310 |
Why?
|
| Female | 120 | 2025 | 30925 | 2.100 |
Why?
|
| Weight Gain | 8 | 2017 | 163 | 2.040 |
Why?
|
| Disabled Persons | 4 | 2024 | 189 | 1.930 |
Why?
|
| Intellectual Disability | 5 | 2022 | 159 | 1.930 |
Why?
|
| Diabetes, Gestational | 8 | 2023 | 138 | 1.890 |
Why?
|
| Mothers | 5 | 2022 | 258 | 1.780 |
Why?
|
| Pre-Eclampsia | 8 | 2024 | 70 | 1.770 |
Why?
|
| Body Mass Index | 12 | 2022 | 837 | 1.740 |
Why?
|
| Mental Health | 14 | 2025 | 336 | 1.640 |
Why?
|
| Pregnancy Outcome | 13 | 2024 | 181 | 1.590 |
Why?
|
| Mass Screening | 9 | 2024 | 651 | 1.560 |
Why?
|
| Pregnant Women | 10 | 2024 | 84 | 1.550 |
Why?
|
| Adult | 65 | 2025 | 15771 | 1.500 |
Why?
|
| Humans | 125 | 2025 | 59737 | 1.500 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 7 | 2024 | 20 | 1.490 |
Why?
|
| Contraception Behavior | 2 | 2024 | 36 | 1.360 |
Why?
|
| Contraception | 4 | 2024 | 68 | 1.330 |
Why?
|
| Pregnancy Proteins | 5 | 2013 | 16 | 1.230 |
Why?
|
| Young Adult | 31 | 2025 | 4290 | 1.070 |
Why?
|
| Pregnancy, High-Risk | 5 | 2014 | 18 | 1.040 |
Why?
|
| Anxiety Disorders | 4 | 2025 | 187 | 1.020 |
Why?
|
| Anxiety | 9 | 2023 | 388 | 0.990 |
Why?
|
| Child Psychiatry | 3 | 2023 | 39 | 0.960 |
Why?
|
| Mood Disorders | 2 | 2025 | 69 | 0.950 |
Why?
|
| Hypertension | 4 | 2023 | 570 | 0.930 |
Why?
|
| Mental Disorders | 6 | 2025 | 724 | 0.930 |
Why?
|
| Intention | 2 | 2024 | 64 | 0.880 |
Why?
|
| Bipolar Disorder | 6 | 2023 | 243 | 0.880 |
Why?
|
| Obesity | 11 | 2023 | 1170 | 0.880 |
Why?
|
| Patient Acceptance of Health Care | 7 | 2019 | 456 | 0.870 |
Why?
|
| Antigens, CD | 3 | 2013 | 343 | 0.840 |
Why?
|
| Postnatal Care | 3 | 2018 | 41 | 0.830 |
Why?
|
| Peripartum Period | 3 | 2024 | 21 | 0.810 |
Why?
|
| Substance-Related Disorders | 4 | 2025 | 688 | 0.780 |
Why?
|
| United States | 25 | 2025 | 7448 | 0.770 |
Why?
|
| Contraceptive Agents | 1 | 2022 | 12 | 0.770 |
Why?
|
| Receptors, Cell Surface | 3 | 2013 | 428 | 0.770 |
Why?
|
| Adolescent | 21 | 2025 | 5866 | 0.750 |
Why?
|
| Massachusetts | 16 | 2025 | 2027 | 0.750 |
Why?
|
| Hysterectomy | 2 | 2021 | 67 | 0.750 |
Why?
|
| Cesarean Section | 3 | 2024 | 97 | 0.740 |
Why?
|
| Hyperglycemia | 1 | 2022 | 98 | 0.730 |
Why?
|
| Psychiatry | 4 | 2024 | 114 | 0.720 |
Why?
|
| Infant, Newborn | 11 | 2024 | 1289 | 0.720 |
Why?
|
| Health Expenditures | 2 | 2019 | 116 | 0.710 |
Why?
|
| Emergency Service, Hospital | 2 | 2019 | 1024 | 0.700 |
Why?
|
| Education, Distance | 1 | 2021 | 34 | 0.700 |
Why?
|
| Breast Feeding | 1 | 2022 | 144 | 0.660 |
Why?
|
| Retrospective Studies | 17 | 2024 | 6153 | 0.650 |
Why?
|
| Hospitalization | 5 | 2025 | 1300 | 0.650 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2018 | 112 | 0.650 |
Why?
|
| Psychological Techniques | 1 | 2019 | 5 | 0.650 |
Why?
|
| Infant | 9 | 2024 | 1496 | 0.650 |
Why?
|
| Mental Health Services | 5 | 2024 | 269 | 0.640 |
Why?
|
| Psychosocial Support Systems | 1 | 2019 | 11 | 0.640 |
Why?
|
| Health Personnel | 3 | 2021 | 343 | 0.630 |
Why?
|
| Child Health Services | 1 | 2019 | 62 | 0.610 |
Why?
|
| Body Weight | 3 | 2017 | 370 | 0.610 |
Why?
|
| Delivery, Obstetric | 5 | 2024 | 51 | 0.610 |
Why?
|
| Risk Factors | 16 | 2023 | 5011 | 0.610 |
Why?
|
| Placenta Growth Factor | 7 | 2024 | 15 | 0.600 |
Why?
|
| Staff Development | 1 | 2019 | 55 | 0.600 |
Why?
|
| Interleukins | 1 | 2018 | 80 | 0.580 |
Why?
|
| Gynecology | 5 | 2024 | 51 | 0.570 |
Why?
|
| Leadership | 2 | 2019 | 194 | 0.560 |
Why?
|
| Child | 11 | 2023 | 4215 | 0.550 |
Why?
|
| Overweight | 4 | 2022 | 238 | 0.550 |
Why?
|
| Vacuum Extraction, Obstetrical | 1 | 2017 | 2 | 0.550 |
Why?
|
| Angiogenesis Inducing Agents | 3 | 2022 | 13 | 0.530 |
Why?
|
| Thinness | 1 | 2017 | 40 | 0.530 |
Why?
|
| Pregnancy Rate | 1 | 2016 | 30 | 0.510 |
Why?
|
| Pregnancy in Adolescence | 1 | 2016 | 23 | 0.510 |
Why?
|
| Premature Birth | 3 | 2024 | 108 | 0.510 |
Why?
|
| Ambulatory Care | 1 | 2018 | 305 | 0.500 |
Why?
|
| Counseling | 5 | 2018 | 352 | 0.500 |
Why?
|
| Delivery of Health Care | 2 | 2021 | 413 | 0.500 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 588 | 0.480 |
Why?
|
| Rural Population | 4 | 2017 | 188 | 0.470 |
Why?
|
| Guideline Adherence | 3 | 2014 | 296 | 0.460 |
Why?
|
| Biomarkers | 6 | 2024 | 1315 | 0.460 |
Why?
|
| Adipogenesis | 1 | 2015 | 71 | 0.460 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2013 | 17 | 0.450 |
Why?
|
| Qualitative Research | 6 | 2024 | 620 | 0.450 |
Why?
|
| Stress Disorders, Post-Traumatic | 4 | 2022 | 382 | 0.440 |
Why?
|
| Maternal Health Services | 3 | 2023 | 63 | 0.440 |
Why?
|
| Adipose Tissue | 2 | 2020 | 286 | 0.440 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2013 | 35 | 0.430 |
Why?
|
| Directive Counseling | 1 | 2013 | 38 | 0.430 |
Why?
|
| Logistic Models | 5 | 2024 | 1240 | 0.420 |
Why?
|
| Obstetric Labor Complications | 1 | 2013 | 24 | 0.420 |
Why?
|
| Labor, Obstetric | 2 | 2024 | 38 | 0.410 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 2 | 2024 | 36 | 0.410 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2024 | 35 | 0.410 |
Why?
|
| Cross-Sectional Studies | 12 | 2024 | 2390 | 0.410 |
Why?
|
| Veterans | 4 | 2022 | 729 | 0.390 |
Why?
|
| Middle Aged | 17 | 2024 | 16449 | 0.390 |
Why?
|
| Program Evaluation | 4 | 2018 | 471 | 0.380 |
Why?
|
| Child Nutrition Disorders | 2 | 2022 | 19 | 0.380 |
Why?
|
| Health Equity | 2 | 2023 | 42 | 0.370 |
Why?
|
| Inpatients | 1 | 2014 | 292 | 0.370 |
Why?
|
| Malnutrition | 2 | 2022 | 40 | 0.370 |
Why?
|
| Inflammation | 1 | 2018 | 1101 | 0.370 |
Why?
|
| Practice Guidelines as Topic | 3 | 2017 | 707 | 0.360 |
Why?
|
| Nutrition Surveys | 3 | 2022 | 131 | 0.350 |
Why?
|
| Prevalence | 8 | 2024 | 1259 | 0.350 |
Why?
|
| Referral and Consultation | 5 | 2024 | 405 | 0.340 |
Why?
|
| Parity | 5 | 2019 | 72 | 0.330 |
Why?
|
| Healthcare Disparities | 3 | 2024 | 330 | 0.330 |
Why?
|
| Smoking | 1 | 2014 | 827 | 0.310 |
Why?
|
| Academic Medical Centers | 3 | 2019 | 311 | 0.310 |
Why?
|
| Clinical Competence | 1 | 2013 | 688 | 0.310 |
Why?
|
| Self Efficacy | 2 | 2021 | 194 | 0.300 |
Why?
|
| Self Report | 3 | 2017 | 360 | 0.300 |
Why?
|
| Midwifery | 2 | 2023 | 32 | 0.300 |
Why?
|
| Social Media | 2 | 2023 | 116 | 0.300 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2013 | 694 | 0.290 |
Why?
|
| Maternal Health | 2 | 2019 | 15 | 0.290 |
Why?
|
| Glucose Intolerance | 2 | 2022 | 88 | 0.290 |
Why?
|
| Surveys and Questionnaires | 8 | 2023 | 2520 | 0.270 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2023 | 382 | 0.260 |
Why?
|
| India | 7 | 2022 | 150 | 0.250 |
Why?
|
| Health Services | 2 | 2017 | 81 | 0.250 |
Why?
|
| Pregnancy, Unplanned | 2 | 2016 | 22 | 0.250 |
Why?
|
| Cohort Studies | 8 | 2024 | 2387 | 0.240 |
Why?
|
| Prospective Studies | 6 | 2018 | 3090 | 0.240 |
Why?
|
| Endoglin | 3 | 2013 | 10 | 0.240 |
Why?
|
| Maternal Mortality | 2 | 2021 | 12 | 0.230 |
Why?
|
| Health Services Accessibility | 2 | 2021 | 527 | 0.230 |
Why?
|
| Insulin Resistance | 2 | 2020 | 393 | 0.230 |
Why?
|
| Longitudinal Studies | 4 | 2025 | 1192 | 0.220 |
Why?
|
| Research Design | 2 | 2019 | 556 | 0.220 |
Why?
|
| Taste Buds | 1 | 2024 | 4 | 0.220 |
Why?
|
| Uterine Contraction | 1 | 2024 | 11 | 0.220 |
Why?
|
| Persons With Hearing Impairments | 1 | 2024 | 23 | 0.220 |
Why?
|
| Obstetric Labor, Premature | 1 | 2024 | 31 | 0.220 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2024 | 31 | 0.220 |
Why?
|
| Deafness | 1 | 2024 | 33 | 0.220 |
Why?
|
| Delphi Technique | 1 | 2024 | 77 | 0.210 |
Why?
|
| Blood Pressure | 2 | 2023 | 498 | 0.210 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 446 | 0.210 |
Why?
|
| Choice Behavior | 1 | 2024 | 78 | 0.210 |
Why?
|
| Patient Compliance | 2 | 2018 | 350 | 0.210 |
Why?
|
| Fellowships and Scholarships | 1 | 2024 | 99 | 0.210 |
Why?
|
| Feeding Behavior | 2 | 2016 | 254 | 0.210 |
Why?
|
| Compassion Fatigue | 1 | 2023 | 13 | 0.210 |
Why?
|
| Telephone | 2 | 2024 | 116 | 0.200 |
Why?
|
| Sterilization, Reproductive | 1 | 2022 | 7 | 0.200 |
Why?
|
| Incidence | 3 | 2021 | 1245 | 0.200 |
Why?
|
| Cardiomyopathies | 1 | 2024 | 119 | 0.200 |
Why?
|
| International Classification of Diseases | 2 | 2021 | 132 | 0.190 |
Why?
|
| Growth and Development | 1 | 2021 | 8 | 0.190 |
Why?
|
| Dietary Approaches To Stop Hypertension | 1 | 2021 | 9 | 0.190 |
Why?
|
| Achievement | 1 | 2021 | 27 | 0.190 |
Why?
|
| Case-Control Studies | 3 | 2013 | 1061 | 0.180 |
Why?
|
| Oxytocin | 2 | 2024 | 45 | 0.180 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 155 | 0.180 |
Why?
|
| Insurance Claim Review | 2 | 2019 | 76 | 0.180 |
Why?
|
| Gestational Age | 3 | 2024 | 180 | 0.180 |
Why?
|
| Stillbirth | 1 | 2021 | 17 | 0.180 |
Why?
|
| Motivation | 1 | 2024 | 275 | 0.180 |
Why?
|
| Psychotropic Drugs | 1 | 2022 | 81 | 0.180 |
Why?
|
| Electrocardiography | 1 | 2024 | 524 | 0.180 |
Why?
|
| Burnout, Professional | 1 | 2023 | 125 | 0.180 |
Why?
|
| Vaccines | 1 | 2022 | 95 | 0.180 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2020 | 7 | 0.180 |
Why?
|
| Veterans Health | 2 | 2019 | 158 | 0.180 |
Why?
|
| Diet | 3 | 2022 | 497 | 0.170 |
Why?
|
| Social Determinants of Health | 1 | 2023 | 122 | 0.170 |
Why?
|
| Quality of Health Care | 1 | 2025 | 514 | 0.170 |
Why?
|
| Antihypertensive Agents | 1 | 2021 | 163 | 0.170 |
Why?
|
| Child, Preschool | 3 | 2021 | 1802 | 0.170 |
Why?
|
| Reproductive History | 1 | 2019 | 15 | 0.170 |
Why?
|
| Pandemics | 2 | 2023 | 618 | 0.160 |
Why?
|
| Blood Glucose | 3 | 2020 | 461 | 0.160 |
Why?
|
| Odds Ratio | 1 | 2021 | 749 | 0.160 |
Why?
|
| Quality of Life | 3 | 2024 | 1142 | 0.160 |
Why?
|
| Humanities | 1 | 2018 | 1 | 0.160 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2018 | 726 | 0.160 |
Why?
|
| Propensity Score | 1 | 2019 | 146 | 0.160 |
Why?
|
| Health Resources | 1 | 2019 | 88 | 0.150 |
Why?
|
| Cluster Analysis | 1 | 2019 | 248 | 0.150 |
Why?
|
| Income | 2 | 2016 | 157 | 0.150 |
Why?
|
| Socioeconomic Factors | 3 | 2017 | 742 | 0.150 |
Why?
|
| Program Development | 2 | 2017 | 203 | 0.150 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2018 | 43 | 0.150 |
Why?
|
| Parturition | 3 | 2023 | 52 | 0.150 |
Why?
|
| Cognition | 1 | 2021 | 457 | 0.140 |
Why?
|
| Sleep | 2 | 2021 | 215 | 0.140 |
Why?
|
| Pregnancy Trimester, First | 1 | 2017 | 25 | 0.140 |
Why?
|
| Continuity of Patient Care | 2 | 2017 | 170 | 0.140 |
Why?
|
| Quality Improvement | 3 | 2017 | 419 | 0.140 |
Why?
|
| Demography | 2 | 2015 | 170 | 0.140 |
Why?
|
| Health Status | 2 | 2019 | 426 | 0.140 |
Why?
|
| Prejudice | 1 | 2017 | 60 | 0.140 |
Why?
|
| Educational Status | 2 | 2016 | 264 | 0.140 |
Why?
|
| Patient Participation | 1 | 2019 | 216 | 0.140 |
Why?
|
| Weight Reduction Programs | 1 | 2018 | 55 | 0.140 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 159 | 0.140 |
Why?
|
| Venous Thromboembolism | 1 | 2018 | 145 | 0.130 |
Why?
|
| Social Class | 1 | 2017 | 122 | 0.130 |
Why?
|
| Health Care Costs | 1 | 2018 | 202 | 0.130 |
Why?
|
| Oxytocics | 1 | 2017 | 14 | 0.130 |
Why?
|
| International Cooperation | 1 | 2017 | 84 | 0.130 |
Why?
|
| Community Mental Health Services | 1 | 2017 | 88 | 0.130 |
Why?
|
| Primary Health Care | 2 | 2019 | 651 | 0.130 |
Why?
|
| Multivariate Analysis | 2 | 2021 | 909 | 0.130 |
Why?
|
| Gravidity | 1 | 2016 | 12 | 0.130 |
Why?
|
| Poverty | 1 | 2018 | 283 | 0.130 |
Why?
|
| Personality | 1 | 2016 | 25 | 0.130 |
Why?
|
| Food Supply | 1 | 2016 | 51 | 0.130 |
Why?
|
| Heart Failure | 1 | 2024 | 858 | 0.130 |
Why?
|
| Impulsive Behavior | 1 | 2016 | 28 | 0.130 |
Why?
|
| Abortion, Induced | 1 | 2016 | 24 | 0.130 |
Why?
|
| Global Health | 1 | 2017 | 168 | 0.120 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2015 | 3 | 0.120 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2015 | 20 | 0.120 |
Why?
|
| Predictive Value of Tests | 3 | 2024 | 1038 | 0.120 |
Why?
|
| Capillaries | 1 | 2015 | 30 | 0.120 |
Why?
|
| Stress, Psychological | 2 | 2016 | 445 | 0.120 |
Why?
|
| Suicidal Ideation | 1 | 2016 | 113 | 0.120 |
Why?
|
| Antidepressive Agents | 3 | 2024 | 213 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 417 | 0.120 |
Why?
|
| Psychology | 1 | 2015 | 44 | 0.120 |
Why?
|
| Glucose Tolerance Test | 1 | 2015 | 96 | 0.120 |
Why?
|
| Anthropometry | 1 | 2015 | 79 | 0.120 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2015 | 83 | 0.120 |
Why?
|
| Preconception Care | 1 | 2015 | 23 | 0.120 |
Why?
|
| Viral Tropism | 1 | 2015 | 50 | 0.120 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2015 | 53 | 0.120 |
Why?
|
| Patient Education as Topic | 3 | 2018 | 454 | 0.120 |
Why?
|
| Databases, Factual | 4 | 2021 | 818 | 0.120 |
Why?
|
| Adiposity | 1 | 2015 | 76 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 193 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 102 | 0.110 |
Why?
|
| Consensus | 3 | 2024 | 193 | 0.110 |
Why?
|
| Students, Medical | 1 | 2017 | 248 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 297 | 0.110 |
Why?
|
| Fetal Distress | 1 | 2013 | 2 | 0.110 |
Why?
|
| Cell Phone | 1 | 2014 | 42 | 0.110 |
Why?
|
| Labor Stage, Second | 1 | 2013 | 5 | 0.110 |
Why?
|
| Labor Stage, First | 1 | 2013 | 7 | 0.110 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 1104 | 0.110 |
Why?
|
| ROC Curve | 2 | 2024 | 268 | 0.110 |
Why?
|
| Adipocytes | 1 | 2015 | 256 | 0.100 |
Why?
|
| Pilot Projects | 3 | 2023 | 922 | 0.100 |
Why?
|
| Data Collection | 1 | 2013 | 374 | 0.100 |
Why?
|
| Linear Models | 1 | 2013 | 403 | 0.100 |
Why?
|
| Community Health Services | 1 | 2013 | 120 | 0.100 |
Why?
|
| Focus Groups | 2 | 2024 | 289 | 0.100 |
Why?
|
| Algorithms | 2 | 2021 | 981 | 0.090 |
Why?
|
| Pregnancy, Multiple | 2 | 2010 | 10 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 727 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 2018 | 1217 | 0.090 |
Why?
|
| Decision Support Techniques | 1 | 2013 | 180 | 0.090 |
Why?
|
| Family Practice | 1 | 2013 | 208 | 0.090 |
Why?
|
| Male | 4 | 2024 | 27952 | 0.090 |
Why?
|
| Length of Stay | 1 | 2014 | 790 | 0.090 |
Why?
|
| Internet | 1 | 2014 | 451 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 987 | 0.090 |
Why?
|
| HIV-1 | 1 | 2015 | 692 | 0.080 |
Why?
|
| Health Status Disparities | 2 | 2023 | 137 | 0.080 |
Why?
|
| Papanicolaou Test | 1 | 2009 | 42 | 0.080 |
Why?
|
| Vaginal Smears | 1 | 2009 | 54 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2013 | 553 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2023 | 531 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1555 | 0.070 |
Why?
|
| Angiogenic Proteins | 1 | 2008 | 4 | 0.070 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2009 | 135 | 0.070 |
Why?
|
| Papillomavirus Infections | 1 | 2009 | 120 | 0.070 |
Why?
|
| Life Style | 2 | 2022 | 299 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2013 | 1935 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2013 | 755 | 0.060 |
Why?
|
| Morbidity | 1 | 2025 | 113 | 0.060 |
Why?
|
| Sign Language | 1 | 2024 | 10 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2024 | 1489 | 0.060 |
Why?
|
| Endothelin-1 | 1 | 2024 | 7 | 0.060 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2024 | 7 | 0.060 |
Why?
|
| Infant, Low Birth Weight | 1 | 2024 | 56 | 0.060 |
Why?
|
| Phenanthrolines | 1 | 2024 | 10 | 0.060 |
Why?
|
| Genitalia | 1 | 2024 | 9 | 0.060 |
Why?
|
| Dinoprost | 1 | 2024 | 19 | 0.060 |
Why?
|
| Myometrium | 1 | 2024 | 15 | 0.060 |
Why?
|
| Taste | 1 | 2024 | 33 | 0.050 |
Why?
|
| Hearing Loss | 1 | 2024 | 45 | 0.050 |
Why?
|
| Semen | 1 | 2024 | 42 | 0.050 |
Why?
|
| Appointments and Schedules | 1 | 2024 | 55 | 0.050 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2024 | 76 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2024 | 124 | 0.050 |
Why?
|
| Job Satisfaction | 1 | 2023 | 133 | 0.050 |
Why?
|
| Carbohydrates | 1 | 2022 | 39 | 0.050 |
Why?
|
| Acculturation | 1 | 2022 | 33 | 0.050 |
Why?
|
| Pregnancy, Twin | 1 | 2022 | 5 | 0.050 |
Why?
|
| Rural Health | 1 | 2022 | 15 | 0.050 |
Why?
|
| Feedback | 1 | 2022 | 87 | 0.050 |
Why?
|
| Lactation | 1 | 2022 | 66 | 0.050 |
Why?
|
| Growth Disorders | 1 | 2022 | 28 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2024 | 257 | 0.050 |
Why?
|
| Affect | 1 | 2022 | 123 | 0.050 |
Why?
|
| Probability | 1 | 2021 | 170 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2022 | 199 | 0.040 |
Why?
|
| Age Factors | 2 | 2019 | 1511 | 0.040 |
Why?
|
| Pain | 1 | 2024 | 398 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2021 | 108 | 0.040 |
Why?
|
| Weight Loss | 1 | 2023 | 265 | 0.040 |
Why?
|
| Beverages | 1 | 2021 | 66 | 0.040 |
Why?
|
| Cause of Death | 1 | 2021 | 210 | 0.040 |
Why?
|
| Calcium | 1 | 2024 | 557 | 0.040 |
Why?
|
| Insurance, Health | 1 | 2021 | 144 | 0.040 |
Why?
|
| Hospitals, Maternity | 1 | 2019 | 10 | 0.040 |
Why?
|
| Vaccination | 1 | 2022 | 335 | 0.040 |
Why?
|
| Puerperal Disorders | 1 | 2019 | 15 | 0.040 |
Why?
|
| Glucose | 1 | 2022 | 444 | 0.040 |
Why?
|
| Uterine Myomectomy | 1 | 2018 | 1 | 0.040 |
Why?
|
| Mice | 2 | 2024 | 10316 | 0.040 |
Why?
|
| Sexual Partners | 1 | 2019 | 75 | 0.040 |
Why?
|
| Japan | 1 | 2018 | 51 | 0.040 |
Why?
|
| Liver | 1 | 2022 | 798 | 0.040 |
Why?
|
| Ambulatory Care Facilities | 1 | 2018 | 101 | 0.040 |
Why?
|
| Health Promotion | 1 | 2022 | 471 | 0.040 |
Why?
|
| Lung | 1 | 2022 | 926 | 0.030 |
Why?
|
| Psychotherapy | 1 | 2018 | 92 | 0.030 |
Why?
|
| Perception | 1 | 2018 | 168 | 0.030 |
Why?
|
| Capacity Building | 1 | 2017 | 21 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 299 | 0.030 |
Why?
|
| Medical History Taking | 1 | 2017 | 65 | 0.030 |
Why?
|
| Nutritive Value | 1 | 2016 | 29 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2017 | 79 | 0.030 |
Why?
|
| Mentors | 1 | 2017 | 115 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2017 | 142 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2017 | 137 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2016 | 92 | 0.030 |
Why?
|
| Medical Record Linkage | 1 | 2015 | 20 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2018 | 485 | 0.030 |
Why?
|
| Energy Intake | 1 | 2016 | 167 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 210 | 0.030 |
Why?
|
| Exercise | 1 | 2022 | 884 | 0.030 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2019 | 520 | 0.030 |
Why?
|
| Depressive Disorder, Major | 1 | 2017 | 250 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 444 | 0.030 |
Why?
|
| Animals | 2 | 2024 | 19705 | 0.030 |
Why?
|
| Health | 1 | 2014 | 31 | 0.030 |
Why?
|
| Laparoscopy | 1 | 2018 | 450 | 0.030 |
Why?
|
| Time Factors | 1 | 2021 | 3629 | 0.030 |
Why?
|
| Drug Prescriptions | 1 | 2014 | 168 | 0.030 |
Why?
|
| Medical Records, Problem-Oriented | 1 | 2012 | 13 | 0.030 |
Why?
|
| Mobile Applications | 1 | 2014 | 129 | 0.020 |
Why?
|
| Epidemiology | 1 | 2011 | 5 | 0.020 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2011 | 60 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 190 | 0.020 |
Why?
|
| Specialization | 1 | 2011 | 78 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 2095 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2011 | 299 | 0.020 |
Why?
|
| Aged | 2 | 2018 | 13510 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 1570 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 5334 | 0.020 |
Why?
|
| Health Behavior | 1 | 2009 | 452 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 637 | 0.010 |
Why?
|